- Report
- October 2024
- 200 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- October 2024
- 185 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- March 2025
- 184 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- March 2025
- 357 Pages
Global
From €5345EUR$5,600USD£4,478GBP
- Report
- December 2024
- 175 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- April 2022
- 148 Pages
Global
From €5249EUR$5,500USD£4,398GBP
- Report
- September 2023
- 210 Pages
Global
From €4295EUR$4,500USD£3,598GBP
The Pathogen Reduction System market within the Blood Banking industry is a rapidly growing sector. It is focused on the development of technologies and processes that reduce the risk of transfusion-transmitted infections. These systems use a variety of methods, such as ultraviolet light, chemical treatments, and filtration, to reduce the number of pathogens in donated blood. This helps to ensure the safety of the blood supply and reduce the risk of infection for patients.
The Pathogen Reduction System market is driven by the increasing demand for safe and reliable blood products, as well as the need to reduce the risk of transfusion-transmitted infections. This has led to the development of a range of technologies and processes that are used to reduce the number of pathogens in donated blood.
Some of the major companies in the Pathogen Reduction System market include Cerus Corporation, Grifols, Macopharma, and Terumo BCT. Show Less Read more